Association between baseline radiological tumor burden and outcomes in patients with metastatic breast cancer treated with an immune checkpoint inhibitor

被引：0
|
作者：
Brown, Lauren Claire
Moodie, Kate
VanGeelen, Courtney
Dixon-Douglas, Julia
David, Steven Philip
Francis, Prudence A.
Savas, Peter
Loi, Sherene
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Australia
[2] Peter MacCallum Canc Ctr, Caulfield, Australia
[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1103
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors
    Hopkins, Ashley M.
    Kichenadasse, Ganessan
    McKinnon, Ross A.
    Rowland, Andrew
    Sorich, Michael J.
    [J]. SEMINARS IN ONCOLOGY, 2019, 46 (4-5) : 380 - 384
  • [2] Association of the Lung Immune Prognostic Index with outcome in patients with metastatic urothelial cancer treated with immune checkpoint inhibitor
    Pauline, Parent
    Auclin, Edouard
    Mezquita, Laura
    Chanza, Nieves M.
    Dumont, Clement
    Rodriguez-Vida, Alejo
    Lozano, Rebeca
    Vera, Beatriz
    Ratta, Raffaele
    Baciarello, Giulia
    Colomba, Emeline
    Fuerea, Alina
    Besse, Benjamin
    Loriot, Yohann
    Lavaud, Pernelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy
    Uehara, Yuji
    Hakozaki, Taiki
    Kitadai, Rui
    Narita, Kosuke
    Watanabe, Kageaki
    Hashimoto, Kana
    Kawai, Shoko
    Yomota, Makiko
    Hosomi, Yukio
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 135 - +
  • [4] Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
    Jang, Se Ryeong
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Johnson, Jennifer M.
    Wilson, Melissa
    Lu-Yao, Grace
    [J]. JAMA NETWORK OPEN, 2021, 4 (12)
  • [5] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Takuma Matoba
    Kiyoshi Minohara
    Daisuke Kawakita
    Gaku Takano
    Keisuke Oguri
    Akihiro Murashima
    Kazuyuki Nakai
    Sho Iwaki
    Hiroshi Tsuge
    Nobukazu Tanaka
    Sae Imaizumi
    Wataru Hojo
    Ayano Matsumura
    Koji Tsukamoto
    Shinichi Esaki
    Shinichi Iwasaki
    [J]. Scientific Reports, 12
  • [6] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Nakai, Kazuyuki
    Iwaki, Sho
    Tsuge, Hiroshi
    Tanaka, Nobukazu
    Imaizumi, Sae
    Hojo, Wataru
    Matsumura, Ayano
    Tsukamoto, Koji
    Esaki, Shinichi
    Iwasaki, Shinichi
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] Atezolizumab - The first Immune Checkpoint Inhibitor for treating Patients with metastatic Breast Cancer
    Ruckhaeberle, E.
    Fehm, T.
    [J]. ONKOLOGE, 2019, 25 (07): : 621 - 622
  • [8] The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
    Dravillas, Caroline E.
    Coleman, Samuel S.
    Hoyd, Rebecca
    Caryotakis, Griffin
    Denko, Louis
    Chan, Carlos H. F.
    Churchman, Michelle L.
    Denko, Nicholas
    Dodd, Rebecca D.
    Eljilany, Islam
    Hardikar, Sheetal
    Husain, Marium
    Ikeguchi, Alexandra P.
    Jin, Ning
    Ma, Qin
    McCarter, Martin D.
    Osman, Afaf E. G.
    Robinson, Lary A.
    Singer, Eric A.
    Tinoco, Gabriel
    Ulrich, Cornelia M.
    Zakharia, Yousef
    Spakowicz, Daniel
    Tarhini, Ahmad A.
    Tan, Aik Choon
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 1978 - 1990
  • [9] Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Inhibitor
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Makrakis, Dimitrios
    Diamantopoulos, Leonidas
    Enright, Thomas
    Leary, Jacob B.
    Patgunarajah, Ubenthira
    Thomas, Vinay M.
    Swami, Umang
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Barata, Pedro
    Murgic, Jure
    Miletic, Marija
    Johnson, Jeffrey
    Zakharia, Yousef
    Hui, Gavin
    Drakaki, Alexandra
    Duran, Ignacio
    Buznego, Lucia A.
    Barrera, Rafael M.
    Castaneda, David M.
    Rey-Cardenas, Macarena
    Castellano, Daniel
    Nguyen, Charles B.
    Park, Joseph J.
    Alva, Ajjai
    McKay, Rana R.
    Stewart, Tyler F.
    Epstein, Ilana B.
    Bellmunt, Joaquim
    Wright, Jonathan L.
    Gupta, Shilpa
    Grivas, Petros
    Khaki, Ali Raza
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [10] Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients
    Takei, Kohei
    Kijima, Toshiki
    Okubo, Naoya
    Kurashina, Ryo
    Kokubun, Hidetoshi
    Uematsu, Toshitaka
    Betsunoh, Hironori
    Yashi, Masahiro
    Kamai, Takao
    [J]. CANCERS, 2023, 15 (23)
12345